透過您的圖書館登入
IP:3.145.105.108
  • 期刊

以何種Methotrexate方法治療低風險滋養層疾病最佳?

What is the Best Regimen of Methotrexate for Low-Risk Gestational Trophoblastic Disease?

摘要


Methotrexate(MTX)為治療妊娠性滋養層疾病最常使用藥物,特別是在沒有轉移病灶和低危險性患者,單獨使用效果很好,包括:(1)每週注射法;(2)連續5天肌肉注射或靜脈注射法;(3)methotrexate 與folinic acide 隔天注射法,共8天;(4)高劑量methotrexate與folinic acide 連續注射法。雖然對低危險性滋養層疾病最理想的方式仍未確定,但回顧文獻結果,以每2週連續5天methotrexate之方式效果最好,且副作用可被接受。

並列摘要


Patients with nonmetastatic and low-risk metastatic gestational trophoblastic disease should be treated with single-agent methotrexate chemotherapy. Several different chemotherapy protocols have been used, including: (1) weekly intramuscular injection; (2) 5-days intramuscular or intravenous push every other week; (3) methotrexate intramuscular every other day alternating with folinic acid over 8 days with at least a 1-week interval; (4) High dose methotrexate infusion with folinic acid beginning 24 hours after start of methotrexate, repeat every 18 days. The best protocol for treating low-risk trophoblastic disease is uncertain, however, 5-day continuing injection every 2 weeks seems to appear a high effective and well-tolerated treatment in literature review.

延伸閱讀